Auro Laboratories logo

Auro Laboratories financials: balance sheet, profit and loss, cash flow

BSE: 530233Pharmaceuticals & BiotechnologySmall Cap

Auro Laboratories Ltd. · Face value ₹10 · Listed May 1995
Last close ₹229.40up ₹2.35 (1.04%)

Share price at the BSE close on 28 Oct 2026. Previous close ₹227.05.

28 Oct: open ₹238.90, high ₹238.90, low ₹223.10

52-week range of traded prices to 28 Oct 2026
₹159.00Low, 12 Nov 2025₹317.00High, 18 Feb 2026
Market cap
₹143 Cr2,545th largest listed
P/E
30.53
P/B
3.08
Dividend yield
Nonein the last 12 months
ROE
10.5%
ROCE
8.8%
Debt to equity
1.37
Volume, BSE
2,956

Auro Laboratories' financial statements for the 10 years to Mar 2026, standalone: the listed company alone, without its subsidiaries, with the twelve months to Jun 2026 after them.

10 years at a glance

₹ crore, years to March.Auro Laboratories annual reports

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings
352.9Mar 17413.5Mar 18474.46.1Mar 19444.11.8Mar 20547.22.0Mar 21512.813Mar 22532.46.2Mar 23547.826Mar 24191.845Mar 25313.563Mar 26
Peak revenue ₹54 Cr, year to Mar 2021; lowest ₹19 Cr, year to Mar 2025

Operating and net margin, per cent

  • Operating margin
  • Net margin
32.6%4.6%12.2%15.3%14.6%14.1%20.7%9.1%8.3%19.9%17.6%32.6%8.2%8.7%9.4%9.3%13.2%5.6%4.6%14.5%9.5%11.5%Mar 17Mar 19Mar 21Mar 23Mar 25Mar 26

Results for the year to Mar 2026

Standalone: the listed company alone, without its subsidiaries. ₹ crore.

From revenue to net profit

  1. Revenue31
  2. Materials and goods−6.1
  3. Employee costs−5.9
  4. Other expenses−8.8
  5. Operating profit10
  6. Depreciation−2.8
  7. Other income+2.0
  8. One-off items−0.1
  9. Finance costs−4.3
  10. Profit before tax4.8
  11. Tax−1.3
  12. Net profit3.5

What the company owns

  • Plant, investments and other assets₹97 Cr
  • Inventory₹14 Cr
  • Receivables₹9 Cr
  • Cash and bank₹2 Cr

What pays for it: net worth and liabilities

  • Borrowings₹63 Cr
  • Net worth₹46 Cr
  • Other liabilities₹7 Cr
  • Owed to suppliers₹5 Cr

Profit and loss

Standalone, ₹ crore, years to March. The last column is the twelve months to Jun 2026, the latest four quarters added.Auro Laboratories quarterly results

₹ croreMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Filed 29 MayJun 2026Twelve monthsFiled 14 Aug
Revenue from operations35.540.846.843.854.350.952.953.619.430.736.8
31.134.640.037.643.046.248.543.016.020.723.8
Materials and goods bought20.124.728.624.528.532.835.726.69.26.16.9
Employee costs–3.74.15.36.06.24.75.12.55.96.3
Other expenses–6.17.37.98.47.28.111.34.38.810.6
Operating profit before depreciation4.36.26.86.211.24.64.410.73.410.013.1
Operating margin12.2%15.3%14.6%14.1%20.7%9.1%8.3%19.9%17.6%32.6%35.4%
Materials, % of revenue–60.6%61.1%55.9%52.6%64.4%67.5%49.5%47.5%19.7%18.6%
Employee costs, % of revenue–9.1%8.7%12.0%11.1%12.3%8.9%9.6%12.7%19.1%17.1%
Other expenses, % of revenue–15.1%15.6%18.0%15.5%14.2%15.3%21.0%22.3%28.7%28.8%
Depreciation and amortisation0.90.91.01.01.01.01.11.11.12.83.4
Operating profit after depreciation3.55.35.85.110.23.63.39.62.37.29.6
Other income0.50.51.01.00.81.10.91.50.72.01.9
Finance costs1.11.10.70.50.50.80.80.71.14.35.3
Profit before one-off items and tax2.94.76.15.610.53.93.410.31.95.06.2
One-off items––0.00.00.00.00.00.00.0−0.1−0.1
Profit before tax2.94.76.15.610.53.93.410.31.94.86.0
–1.21.71.63.31.01.02.60.01.31.4
Net profit2.93.54.44.17.22.82.47.81.83.54.7
Other comprehensive income––0.10.10.00.10.40.30.1−0.2−0.5
Total comprehensive income––4.54.27.23.02.88.12.03.44.2
Net margin8.2%8.7%9.4%9.3%13.2%5.6%4.6%14.5%9.5%11.5%12.7%
Materials, employee costs and other expenses are shown for the years they add up to operating expenses; for the year to Mar 2017 they do not, so they are left blank.

Balance sheet

Standalone, ₹ crore, at 31 March.

₹ croreMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Filed 29 May
1721293234424346
Share capital66666666
Reserves1115222528363740
622136264563
6682018242229
105534203446
Total assets33324255568699121
2314141720557890
1018283836312231
Net debt2−4−1214254462
Borrowings are counted again inside the liabilities due within a year and after a year. No balance sheet is on record for the years to Mar 2017 and Mar 2018, so its lines and the ratios worked from it are blank there.

Cash flow

Standalone, ₹ crore, years to March.

₹ croreMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Filed 29 May
12.8−6.63.318.85.72.1
12.8−6.63.318.85.82.1
1.0−12.1−2.36.42.0−9.8
Receivables−1.5−6.31.2−1.04.00.2
Inventories1.5−1.7−7.53.54.6−9.9
Payables1.0−0.96.6−5.30.0−1.5
Other working capital0.0−3.2−2.69.1−6.61.4
Capital spending0.44.64.135.623.857.1
Free cash flow12.4−11.2−0.8−16.8−18.1−55.0
−3.5−5.3−5.1−38.7−24.5−14.8
−0.59.8−8.219.117.714.0
Dividends paid0.00.00.00.00.00.0
Shares bought back0.00.00.00.00.00.0
Shares issued0.00.00.00.00.00.0
Net change in cash8.9−2.1−10.0−0.8−1.01.4
Capital spending is part of cash from investing, and dividends paid, shares bought back and shares issued are part of cash from financing. Each is shown as an amount on a line of its own, and the section's other items are in its total only. No cash flow statement is on record for the years to Mar 2017, Mar 2018, Mar 2019 and Mar 2020.

Per share

Standalone, ₹ per share, years to March.

₹ per shareMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Filed 29 May
Earnings per share₹4.69₹5.66––₹11.52₹4.56₹3.92₹12.50₹2.95₹5.67
Diluted earnings per share₹4.69₹5.66––₹11.52₹4.56₹3.92₹12.50₹2.95₹5.67
Book value per share––₹27.94₹34.49₹45.86₹50.58₹54.87₹67.32₹68.94₹74.36
Shareholder yield––––0.0%0.0%0.0%0.0%0.0%0.0%
Market cap at the year end (₹ crore)26543720516334100144165
Earnings per share is left blank for the years to Mar 2019 and Mar 2020: the earnings per share stated does not match any profit the filing states over the shares in issue, and the share count barely moved during the period.

Ratios

Standalone, years to March.Auro Laboratories PE ratio and valuation

RatioMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Filed 29 May
Revenue growth–15.0%14.8%−6.5%23.9%−6.2%4.0%1.4%−63.8%58.5%
Operating profit growth–44.1%9.8%−10.0%82.5%−58.9%−5.0%142.9%−68.1%193.9%
Net profit growth–20.8%24.6%−7.8%77.1%−60.4%−14.2%219.1%−76.4%92.1%
Earnings per share growth–20.7%–––−60.4%−14.0%218.9%−76.4%92.2%
––25.3%20.8%28.7%9.5%7.4%20.5%4.3%7.9%
–––−4.4 pts7.8 pts−19.2 pts−2.0 pts13.0 pts−16.1 pts3.6 pts
From the net margin–––−0.4 pts8.9 pts−16.6 pts−1.7 pts16.0 pts−7.1 pts0.9 pts
From asset turnover–––−1.2 pts2.9 pts−3.4 pts−0.7 pts−4.8 pts−9.6 pts1.7 pts
From borrowing–––−2.8 pts−4.0 pts0.8 pts0.3 pts1.9 pts0.6 pts0.9 pts
Return on capital employed––24.8%22.0%33.3%8.1%8.2%14.0%2.6%6.6%
Cash conversion––––178.5%−231.7%134.4%241.4%312.5%59.8%
Interest cover3.24.98.111.022.34.44.113.02.11.7
Debt to equity––0.350.080.070.410.180.631.051.37
Receivable days––04849988691177109
Inventory days––43613347120113145815
Payable days––6671745411785246282
Cash conversion cycle, days––−23388918811976642
Working capital days––−3513512413589210244
Asset turnover––1.401.331.461.050.950.760.210.28
Assets per rupee of net worth––1.921.691.481.611.691.862.182.47
Sales per rupee of plant––3.213.084.003.744.192.420.920.41
Capital spending to depreciation––––0.364.533.7932.6321.7120.33
Plant being built, % of plant in use––0.8%0.8%1.0%27.0%60.8%147.5%268.2%19.3%
No balance sheet is on record for the years to Mar 2017 and Mar 2018, so its lines and the ratios worked from it are blank there.

Growth and returns over 3, 5 and 10 years

Standalone: the listed company alone, without its subsidiaries. Each window ends with the year to Mar 2026.

Return on assets, latest year
3.2%
Cash from operations against operating profit
21.1%
Measure10 years5 years3 years
Revenue growth, yearly rate–−10.7%−16.5%
Profit growth, yearly rate–−13.2%13.1%
Return on equity, average–9.9%10.9%
Return on capital employed, average–7.9%7.7%
Operating margin, average16.4%17.5%23.3%
Net margin, average9.4%9.1%11.8%
Asset turnover, average–0.650.42
Cash conversion cycle, days, average–203279
Interest cover, average7.55.15.6
Debt to equity, average–0.731.01

Where the cash came from and went

Standalone: the listed company alone, without its subsidiaries. ₹ crore, added up over each window, which ends with the year to Mar 2026.

₹ crore5 years3 yearsLatest year
Cash from operations23272
Cash from investing−88−78−15
Cash from financing525114
Capital spending12511757
Dividends paid000
Shares bought back000
Shares issued for cash000
Borrowings raised56438
Borrowings repaid221310

Accounting checks

Standalone, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Piotroski score, out of 9Published threshold 3 points out of 9–––935657
Altman Z-scorePublished threshold 1.81–4.064.165.753.833.213.112.352.31
Beneish M-scorePublished threshold −1.78–––−2.974.69−2.06−2.56−2.27−2.82
Profit not backed by cash, % of assetsPublished threshold 10 per cent of average total assets–––−5.7330.527.6539.0322.2314.72
Cash from operations to profit, 3 yearsPublished threshold 0.7 times–––––0.761.182.312.03
Receivables growth less revenue growthOur threshold 0 percentage points–––2.4092.75−12.876.5633.97−61.05
Inventory growth less cost-of-goods growthOur threshold 0 percentage points––34.88−53.9352.24167.42−4.319.85303.32
Other current assets growth less revenue growthOur threshold 5 per cent of revenue––−0.702.497.063.25−2.821.29−4.61
Assets under construction, years of additionsOur threshold 2 years of additions––0.170.383.4493.853.0813,133.770.25
Effective tax ratePublished threshold 17.16 per cent25.3427.5128.1331.6626.5729.1324.682.2426.52
Tax charged less tax paid, % of profitOur threshold 10 percentage points––––26.5729.1324.682.2426.52
A threshold marked as ours has no published figure; it is the line we read the check against.

Credit ratings

An agency's view of the chance the company repays a borrowing on time, from AAA, the highest, down to D, in default.

DateAgencyBorrowing ratedRatingOutlookAmount, ₹ Cr
10 Apr 2026Acuite Ratings & Research LimitedBank Loan RatingsLong-term scaleACUITE BB+NAStable64.20
10 Apr 2026Acuite Ratings & Research LimitedBank Loan RatingsShort-term scaleACUITE A4+NA15.60
25 Aug 2025CRISIL Ratings LimitedBank FacilitiesShort-term scaleWithdrawnRating Withdrawn0.60
25 Aug 2025CRISIL Ratings LimitedBank FacilitiesLong-term scaleWithdrawnRating Withdrawn4.50
25 Aug 2025CRISIL Ratings LimitedBank FacilitiesShort-term scaleWithdrawnRating Withdrawn5
25 Aug 2025CRISIL Ratings LimitedBank FacilitiesLong-term scaleWithdrawnRating Withdrawn31.90
The latest rating on each borrowing. The agency's name opens its reasoning for the rating.